Showing 1801-1810 of 3225 results for "".
The Skin After Cancer
https://practicaldermatology.com/topics/general-topics/the-skin-after-cancer/20797/There are lots of questions, but still few answers. Here's what we know.Step Up Your Approach to Fungal Infections
https://practicaldermatology.com/topics/general-topics/PD0709_03-php/22798/From choosing and using topical therapies to targeting onychomycosis, here are pointers for management of fungal diseases.Can Technology Help Dermatology Rediscover Its Roots?
https://practicaldermatology.com/topics/practice-management/can-technology-help-dermatology-rediscover-its-roots/20314/If you think of health information technology only as electronic medical records, you may be dismissing a range of valuable tools.Enhancing Treatment Adherence
https://practicaldermatology.com/topics/practice-management/enhancing-treatment-adherence/21083/Devising a strategy to engage patients in their treatment regimen for better results.Complex Adaptive Systems Approach: Continuous Quality Improvement Assessments Applied to Dermatology
https://practicaldermatology.com/topics/general-topics/complex-adaptive-systems-approach-continuous-quality-improvement-assessments-applied-to-dermatology/21103/Part II- Applied to Systemic Lupus ErythematosusBiologic Therapies for 2013: Do We Use Them Enough?
https://practicaldermatology.com/topics/psoriasis/biologic-therapies-for-2013-do-we-use-them-enough/22931/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20945/When Topicals Fail: The New IPC Consensus Every Clinician Should Know
https://practicaldermatology.com/programs/cme/when-topicals-fail-the-new-ipc-consensus-every-clinician-should-know/39967/Review IPC’s 2025 consensus guidance on reclassifying psoriasis severity and redefining failure of topical therapies.Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-31/23656/